Dolby Laboratories Inc. (DLB) Tops Q3 EPS by 11c; Issues Very Strong FY11 Outlook; Announces $250M Buyback; Trading Halted
Dolby Laboratories Inc. (NYSE: DLB) reported Q3 EPS of $0.65, $0.11 better than the analyst estimate of $0.54. Revenue for the quarter came in at $219 million versus the consensus estimate of $216.1 million.
Dolby Laboratories Inc. sees FY2011 EPS of $2.87-$2.96, versus the consensus of $2.60. Dolby Laboratories Inc. sees FY2011 revenue of $930-$955 million, versus the consensus of $932.18 million.
Announces a $250 million buyback plan.
Dolby Laboratories Inc. sees FY2011 EPS of $2.87-$2.96, versus the consensus of $2.60. Dolby Laboratories Inc. sees FY2011 revenue of $930-$955 million, versus the consensus of $932.18 million.
Announces a $250 million buyback plan.